Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001486570 | SCV001691030 | likely benign | Jeune thoracic dystrophy | 2024-05-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002562708 | SCV003533847 | uncertain significance | Inborn genetic diseases | 2021-10-06 | criteria provided, single submitter | clinical testing | The c.4576C>A (p.Q1526K) alteration is located in exon 30 (coding exon 30) of the DYNC2H1 gene. This alteration results from a C to A substitution at nucleotide position 4576, causing the glutamine (Q) at amino acid position 1526 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV004719162 | SCV005325575 | uncertain significance | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |